| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1046375799 |
| P356 | DOI | 10.1186/CC11361 |
| P932 | PMC publication ID | 3580642 |
| P698 | PubMed publication ID | 22632574 |
| P5875 | ResearchGate publication ID | 225062146 |
| P50 | author | Greet Van den Berghe | Q41203524 |
| Michael P Casaer | Q57647247 | ||
| P2093 | author name string | Ann Maes | |
| Alexander Wilmer | |||
| Pieter J Wouters | |||
| Dieter Mesotten | |||
| Steven Simoens | |||
| Jasperina Dubois | |||
| Guido Peers | |||
| Jocelijn Coenegrachts | |||
| Katleen Polders | |||
| Katrien Kesteloot | |||
| Simon Vanderheyden | |||
| Thomas De Rijdt | |||
| Tine Grieten | |||
| P2860 | cites work | How should cost data in pragmatic randomised trials be analysed? | Q30593090 |
| Analysis and interpretation of cost data in randomised controlled trials: review of published studies | Q31987799 | ||
| Health economic assessment: a methodological primer | Q33566896 | ||
| Impact of early parenteral nutrition completing enteral nutrition in adult critically ill patients (EPaNIC trial): a study protocol and statistical analysis plan for a randomized controlled trial. | Q34552719 | ||
| Economic evaluation of new therapies in critical illness | Q35052394 | ||
| Combination enteral and parenteral nutrition in critically ill patients: harmful or beneficial? A systematic review of the evidence | Q35797227 | ||
| Common methodological flaws in economic evaluations. | Q36213762 | ||
| Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report | Q36263674 | ||
| Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party | Q36599584 | ||
| Economic impact and quality of life as endpoints of nutritional therapy | Q37187279 | ||
| Nutrition support in the intensive care unit: an evolving science | Q37766730 | ||
| Impact of nosocomial infections on clinical outcome and resource consumption in critically ill patients | Q38926220 | ||
| Early indicators of prolonged intensive care unit stay: impact of illness severity, physician staffing, and pre-intensive care unit length of stay | Q40608727 | ||
| Economic benefits of intensive insulin therapy in critically Ill patients: the targeted insulin therapy to improve hospital outcomes (TRIUMPH) project | Q41274819 | ||
| Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis | Q43606634 | ||
| Hospital-acquired infections in Belgian acute-care hospitals: an estimation of their global impact on mortality, length of stay and healthcare costs | Q46236407 | ||
| Cost analysis of intensive glycemic control in critically ill adult patients | Q46990703 | ||
| Treatment of the critically ill patient with protein C: is it worth the cost? | Q51803144 | ||
| Early versus Late Parenteral Nutrition in Critically Ill Adults | Q57245243 | ||
| Parenteral with enteral nutrition in the critically ill | Q74319482 | ||
| Understanding costs and cost-effectiveness in critical care: report from the second American Thoracic Society workshop on outcomes research | Q77648646 | ||
| Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients | Q82748991 | ||
| Determining the economic cost of ICU treatment: a prospective "micro-costing" study | Q84564061 | ||
| P433 | issue | 3 | |
| P304 | page(s) | R96 | |
| P577 | publication date | 2012-05-25 | |
| P1433 | published in | Critical Care | Q5186602 |
| P1476 | title | Early versus late parenteral nutrition in ICU patients: cost analysis of the EPaNIC trial | |
| P478 | volume | 16 |
| Q34419891 | Acute outcomes and 1-year mortality of intensive care unit-acquired weakness. A cohort study and propensity-matched analysis |
| Q39120623 | An official American Thoracic Society/American Association of Critical-Care Nurses/American College of Chest Physicians/Society of Critical Care Medicine policy statement: the Choosing Wisely® Top 5 list in Critical Care Medicine |
| Q90185152 | Association of Baseline Inflammation With Effectiveness of Nutritional Support Among Patients With Disease-Related Malnutrition: A Secondary Analysis of a Randomized Clinical Trial |
| Q43492860 | Commentary on: monitoring of residual gastric volume during enteral nutrition: influence on the incidence of ventilator-associated pneumonia in ventilated patients |
| Q48537206 | Cost-effectiveness study of early versus late parenteral nutrition in critically ill children (PEPaNIC): preplanned secondary analysis of a multicentre randomised controlled trial |
| Q37045131 | Early parenteral nutrition in critically ill patients with short-term relative contraindications to early enteral nutrition: a full economic analysis of a multicenter randomized controlled trial based on US costs |
| Q61820610 | Early versus late parenteral nutrition in critically ill, term neonates: a preplanned secondary subgroup analysis of the PEPaNIC multicentre, randomised controlled trial |
| Q38527065 | Glucose management in critically ill adults and children |
| Q30303072 | Hypocaloric compared with eucaloric nutritional support and its effect on infection rates in a surgical intensive care unit: a randomized controlled trial |
| Q35576744 | Impact of withholding early parenteral nutrition completing enteral nutrition in pediatric critically ill patients (PEPaNIC trial): study protocol for a randomized controlled trial |
| Q36560232 | LOGIC-insulin algorithm-guided versus nurse-directed blood glucose control during critical illness: the LOGIC-1 single-center, randomized, controlled clinical trial |
| Q89992817 | Medical Nutrition Therapy in Critically Ill Patients Treated on Intensive and Intermediate Care Units: A Literature Review |
| Q97564477 | Meeting Nutritional Targets of Critically Ill Patients by Combined Enteral and Parenteral Nutrition: Review and Rationale for the EFFORTcombo trial |
| Q36376463 | Nutrition support in hospitalised adults at nutritional risk. |
| Q38527073 | Nutritional support in critical illness and recovery |
| Q36753909 | Overview of progresses in critical care medicine 2012. |
| Q57245212 | Role of Disease and Macronutrient Dose in the Randomized Controlled EPaNIC Trial |
| Q92374177 | The soluble mannose receptor (sMR/sCD206) in critically ill patients with invasive fungal infections, bacterial infections or non-infectious inflammation: a secondary analysis of the EPaNIC RCT |
| Q57245200 | Tight glycaemic control in critically ill children |
| Q26865251 | Timing of (supplemental) parenteral nutrition in critically ill patients: a systematic review |
| Q43478259 | Withholding parenteral nutrition during critical illness increases plasma bilirubin but lowers the incidence of biliary sludge |
| Q33754610 | Year in review 2012: Critical Care--management |
Search more.